BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with ...
BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion ...
BURLINGTON, Mass, May 19, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, ...
View Bone Biologics Corp. BBLG stock quote prices, financial information, real-time forecasts, and company news from CNN.
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, provides an update on its clinical development ...
Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics," or the "Company"), a developer of orthobiologic products for spine fusion markets ...
Bone Biologics Corporation (BBLG) announced it has entered into a definitive agreement with a single healthcare-focused institutional investor for an at-the-market private placement expected to yield ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (BBLG) (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results